Page 165 - Total War on PTSD

gravitating toward [Marijuana] products with high THC levels, which may help in the short-term but are likely to worsen their symptoms over time.”
Regardless of the current legislative ‘workings’, Cannabis research still advances slowly. There are still multiple challenges, laws, and limitations on testing material with which to conduct actual studies. Dr. Suzanne Sisley, who was mentioned earlier, is the lead for Phase 2 of the study, which is part of the Multidisciplinary Association for Psychedelic Studies, better known as MAPS. The organization is a research institute that is focused on exploring uses of Cannabis and psychedelics on a medicinal basis. Sisley’s project specifically on how Cannabis affects Veterans with PTSD. Her project initially received approval from the Public Health Service in 2014; and later that same year, the Colorado Department of Public Health and Environment awarded a $2 million grant to complete the research. A little more than a year after the research began, in January of 2018, Sisley’s project is in its official Phase 2 Clinical Trial Phase. Sisley is hopeful that, at the completion of the project, she will have a more concrete understanding of Marijuana and its impact on PTSD and, in particular, how medicinal Marijuana can be used to assist military Veterans with PTSD.
Last year, the CDC reported that 66,000 Americans died in the opioid crisis. That is more than twenty 9/11’s. If these Veterans can finally find a safe, effective alternative to the “zombie cocktail” of opioids that have been forced on them, it is worth having the VA at least study CBD. If we really want to honor our Veterans, we should stop poisoning them with a deadly array of opiate based medications and start listening to them when they tell us in their own words what works. Wouldn’t that put some meaning behind the standard platitude, “Thank you for your service?” **Visit https://warfighterhemp.com for more information.**
165 of 1042